Vicore Pharma Holding AB
Developing novel ATRAG drugs for severe respiratory diseases.
Oversigt
- 5–9
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 2005
- Grundlagt
Beskrivelse
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...